Since high levels of IL-10 have been demonstrated to ameliorate the pathology of mdx mice [160,161], these new results on HDAC11 functions are promising and open new avenues for the development of more specific HDAC inhibitors, such as specific HDAC11 inhibitors, as an effective approach to treat MDs. The gene discussed is HDAC9; the disease is myelodysplastic syndrome.